ARCHIVES

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

This article is from The Cancer Letter archive.

Vol. 18 No. 41 | October 23, 1992

Download PDF Visit The Full Archive

Related Articles

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

Sausville to lead clinical research at Maryland.

December 5, 2003

Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications

March 18, 1977

In Brief: NCI Can Proceed With Grant, Contract Awards At Full FY 1978 Level; Rundles Heads ACS

November 18, 1977

NIES Issue RFA For Studies On Alternative Types Of Cancer Bioassay

October 31, 1980